Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2006-04-01
Edice:	AIDS Research and Therapy
On-line přístup:	http://www.aidsrestherapy.com/content/3/1/11
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!